GERMANY – EMBL Ventures leads EUR 4.5m vasopharm funding
EMBL Ventures, alongside HeidelbergCapital, Entrepreneurs Fund and KfW, has backed biotechnology company vasopharm GmbH with an investment of EUR 4.5m.
Würzburg-based vasopharm GmbH is active in the discovery and development of novel therapeutics. Its compound VAS 203 is intended to be used in the treatment of craniocerebral trauma and two further indications.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Czech Republic-headquartered family office is targeting DACH and CEE region deals
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds
Back to Top








